Evidence map›Paper›PMID 31905923›Full record

ReviewBiomolecules2019

Neuroprotective Effects of Quercetin in Alzheimer's Disease.

Haroon Khan, Hammad Ullah, Michael Aschner, Wai San Cheang, Esra Küpeli Akkol

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 231 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
231citing papers in PubMed, 3 pooled it
27.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

231 citing papers in PubMed, 3 syntheses or guidelines pooled it, 503 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Investigation of the Potential Neuroprotective Mechanisms ofInternational journal of molecular sciences · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. [Quercetin, a key bioactive component of Zuogui Pill, protects against AlzheimerZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Article
  18. Article
  19. Article
  20. Article

171 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Haroon KhanDepartment of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan.ORCID 0000-0002-1736-4404
Hammad UllahDepartment of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan.ORCID 0000-0003-0668-8806
Michael AschnerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer 209, 1300 Morris Park Avenue, Bronx, NY 10461, USA.ORCID 0000-0002-2619-1656
Wai San CheangInstitute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macau, China.ORCID 0000-0002-1152-7997
Esra Küpeli AkkolDepartment of Pharmacognosy, Faculty of Pharmacy Gazi University, 06330 Etiler/Ankara, Turkey.ORCID 0000-0002-5829-7869
Abdul Wali Khan University Mardan · PKAlbert Einstein College of Medicine · USGazi University · TRUniversity of Macau · MO

Funding

Genetic Modulation of MeHg-Induced Oxidative Stress in the Developing BrainR01ES020852 · NIEHS · VANDERBILT UNIVERSITY · PI ASCHNER, MICHAEL · 2012 to 2016
$1.8M
NIEHS NIH HHS R01 ES020852
6 · The paper itself

Abstract

Quercetin is a flavonoid with notable pharmacological effects and promising therapeutic potential. It is widely distributed among plants and found commonly in daily diets predominantly in fruits and vegetables. Neuroprotection by quercetin has been reported in several in vitro studies. It has been shown to protect neurons from oxidative damage while reducing lipid peroxidation. In addition to its antioxidant properties, it inhibits the fibril formation of amyloid-β proteins, counteracting cell lyses and inflammatory cascade pathways. In this review, we provide a synopsis of the recent literature exploring the relationship between quercetin and cognitive performance in Alzheimer's disease and its potential as a lead compound in clinical applications.

Indexed as

AcetylcholinesteraseAlzheimer DiseaseAmyloid beta-PeptidesAnimalsAntioxidantsCholinesterase InhibitorsHumansNeuroprotective AgentsOxidative StressProtein AggregatesQuercetinAcetylcholinesteraseAmyloid beta-PeptidesAntioxidantsCholinesterase InhibitorsNeuroprotective AgentsProtein AggregatesQuercetinAlzheimer’s diseaseclinical directionsmechanistic insightspolyphenolsquercetin

Identifiers

PMID31905923
PMCPMC7023116
OpenAlexW2997032704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.